Reading the tape
NYSE: SOLV
Solventum Corporation
Healthcare · Medical - Care Facilities
Market Cap
$11.84B
52w High
$88.20
52w Low
$62.38
P/E
7.64
Volume
608.72K
Outstanding Shares
173.49M
Price vs Fundamentals
Why The Stock Is Moving
Mixed / unclearLow confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: 1.28%Revenue (TTM): 0.86%FCF (TTM): -101.24%P/E: 0th pct
What changed
The stock rose 1.28% over the last year. Revenue grew 0.86% over the trailing twelve months. Operating margin moved from 12.55% to 26.2%. Free cash flow declined 101.24% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 26.2%. A decisive move in revenue — currently up 0.86% — would be the clearest signal to resolve the ambiguity.
Company profile
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs.
CEOBryan C. Hanson
SectorHealthcare
IndustryMedical - Care Facilities
Employees22,000
IPO dateApr 1, 2024
Valuation
Forward P/E—
EV/EBITDA7.04
Enterprise value$17.95B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth-3.71%
Gross margin53.47%▼3.92%vs FY2024
Operating margin26.2%▲108.73%vs FY2024
ROE30.82%▲90.38%vs FY2024
Analyst consensus
RatingBuy
Target price$97.80▲43.32%
7
Buy
3
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 5, 2026
Q2 FY26 · EPS est $1.35 · Revenue est $1.97B
View